Evogene Completes Sale of Lavie Bio to ICL

Evogene has finalized the sale of its subsidiary Lavie Bio to ICL, including the transfer of its MicroBoost AI platform.

Evogene has completed the sale of its ag-biologicals subsidiary, Lavie Bio, to ICL, as announced in a press release. The transaction includes the transfer of Lavie Bio's proprietary Biology Driven Design technology platform, microbial bank, and advanced development programs.

In addition to these assets, Evogene has also transferred its MicroBoost AI for AG platform to ICL. This platform is designed to accelerate microbial product development in agriculture. The core personnel of Lavie Bio will also transition to ICL as part of the agreement.

Lavie Bio's existing strategic partnerships and commercial agreements remain under its ownership, potentially yielding future revenues for its shareholders. This transaction aligns with Evogene's strategy to unlock the value of its subsidiaries and technologies.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Healthcare & Life Sciences AI

AI Brief (X)

More from: Funding

Pimloc Secures €4.2 Million for AI Video Privacy Expansion

Jul 08

Mistral AI in Talks for $1 Billion Funding with MGX

Jul 08

Galbot Secures $151 Million to Expand AI Humanoid Robots

Jul 08

15below Acquires Airport AI to Enhance Air Travel Communication

Jul 08

First Choice Health Acquires Orderly Health for Enhanced Data Management

Jul 08

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.